<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="Content-Type" content="text/html">
  <meta name="description" content="Compilation of extracted CSS styles on the SCP Wiki">
  <meta name="keywords" content="scp,wiki,styles,wikidot">
  <meta name="author" content="SCP Wiki">
  <meta name="generator" content="wikidot-css-extractor">

  <script src="https://tristen.ca/tablesort/dist/tablesort.min.js"></script>
<script src="https://tristen.ca/tablesort/dist/sorts/tablesort.number.min.js"></script>
<script src="https://emmiegit.github.io/wikidot-css-extractor/static/script.js" async></script>
  <link rel="stylesheet" href="https://tristen.ca/tablesort/tablesort.css">
<link rel="stylesheet" href="https://emmiegit.github.io/wikidot-css-extractor/static/style.css">

  <title>The Mementos</title>
</head>
<body>
<div id="container">
  
  <div class="page">
    <h1 class="title">The Mementos</h1>
    <p>
      Link to article: <a href="https://scp-wiki.wikidot.com/fragment:psul-001-7" target="_blank">The Mementos</a>.
    </p>

    <h2 class="header">Module Styles</h2>
    <ul class="module-styles">
      
        <li>
          <pre><code>.computed {
border: 1px black solid;
width: 50%;
display: inline-block;
text-align: left;
padding: 3px;
}
.computed:before {
content:&#34;Computed Code&#34;;
font-weight: bold;
border-bottom: solid 1px black;
width: 100%;
}
.rawcode {
border: black solid 1px;
width: 50%;
display: inline-block;
text-align: left;
padding: 3px;
}
.rawcode:before{
content:&#34;Raw Code&#34;;
text-align: center;
font-weight: bold;
border-bottom: solid 1px black;
width: 100%;
}
.codebox {
display: inline-block;
width: 100%;
text-align: center;
}
.yui-navset .yui-nav .selected a em,  .yui-navset .yui-nav a em{
padding: 0.25em .75em; 
top: 0px;
margin-bottom: 0px;
}
.yui-navset .yui-nav .selected a {
background: gray;
}
.yui-navset .yui-nav .selected {
margin: 0px;
}
.yui-navset .yui-nav .selected a, .yui-navset .yui-nav .selected a:focus, .yui-navset .yui-nav .selected a:hover, .yui-navset .yui-nav .selected a {
background: gray;
}
.yui-navset .yui-nav a, .yui-navset .yui-navset-top .yui-nav a {
background-color: none;
background-image: none;
}
.yui-navset .yui-nav a {
background: none;
}
.yui-navset .yui-nav li{
margin: 0px;
}
.yui-navset .yui-content {
background-color: #FDFCF9; 
}</code></pre>
        </li>
      
    </ul>

    <h2 class="header">Inline Styles</h2>
    <ul class="inline-styles">
      
        <li>
          (none)
        </li>
      
    </ul>

    <h2 class="header">Includes</h2>
    <ul class="includes">
      
        <li>(none)</li>
      
    </ul>

    <h2 class="header">CSS Classes</h2>
    <ul class="css-classes">
      
        <li>
          (none)
        </li>
      
    </ul>

    <h2 class="header">Page Source</h2>
    <pre><textarea class="page-source" readonly>[[tabview]]
[[tab Incomplete medical records - 1947]]

**Medical Records - Site 19 - Project Amrita**

&gt; **Subject No.:** 139
&gt; 
&gt; **Name:** Stephen Moore
&gt; 
&gt; **Time elapsed:** 174 days
&gt; 
&gt; **Observations:** Skin samples indicate thickening of cell membranes and accelerated production of corneocytes. Keratin filament network appears to be based on a recombinant keratin variant, with increased strength and resilience and reduced elasticity. Rate of desquamation reduced to 20% of normal levels.

&gt; **Subject No.:** 85
&gt; 
&gt; **Name:** &lt;illegible&gt;
&gt; 
&gt; **Time elapsed:** 217 days
&gt; 
&gt; **Observations:** Subject&#39;s health remains within normal parameters. No evidence of RS Amrita having any effect.

&gt; **Subject No.:** 127
&gt; 
&gt; **Name:** Michael Taubman
&gt; 
&gt; **Time elapsed:** 235 days
&gt; 
&gt; **Observations:** Genetic sequencing shows evidence of reduction in telomere shortening. No observable symptoms or health benefits.

&gt; **Subject No.:** 188
&gt; 
&gt; **Name:** Susan Parker
&gt; 
&gt; **Time elapsed:** 282 days
&gt; 
&gt; **Observations:** Metabolism has decreased to extremely low levels. Red blood cells exhibit greatly increased oxygen storage capacity, resulting in slower blood flow and increased muscle endurance.

&gt; **Subject No.:** 14
&gt; 
&gt; **Time elapsed:** 250 days
&gt; 
&gt; **Observations:** Subject reports no unusual symptoms or results. All tests normal.

&gt; **Subject No.:** 85
&gt; 
&gt; **Name:** &lt;illegible&gt;
&gt; 
&gt; **Time elapsed:** 301 days
&gt; 
&gt; **Observations:** Subject rendered spontaneously immobile and non-responsive. No observable respiration or heart rate. Body unable to be moved or manipulated. Cause unclear.

&gt; **Subject No.:** 71
&gt; 
&gt; **Name:** Captain Raymond Lewis
&gt; 
&gt; **Age:** 49
&gt; 
&gt; **Administered:** RS-Amrita B.21 - standard dosage. Delivery: intravenous. Action: &lt;paper burned&gt;
&gt; 
&gt; **Time elapsed:** 370 days
&gt; 
&gt; **Observations:** Subject&#39;s health remains stable. Blood results clear. Subject reports increased alertness, vigor and sense of well-being.
&gt; 
&gt; Abnormal bone growth in mandible, maxillary and zygomatic regions appears to have stabilised, and remains typical for B.21 patients. Subject reports no major discomfort.
&gt; 
&gt; Results of physical testing are attached.

[[/tab]]
[[/tabview]]
@@@@
[[tabview]]
[[tab Interview transcript]]

**Project Amrita - Interview 071-005**
 
__Date:__ 26 April 1947

__Present:__ O5-1, Amrita Test Subject 71 (Raymond Lewis), Lt. Charles Taylor (MTF Alpha-1)

&gt; **O5-1:** Morning, Ray.
&gt; 
&gt; **Lewis:** Good morning, sir - ha, sorry.  Taylor, good to see you.
&gt; 
&gt; **Taylor:** Good morning, sir.
&gt; 
&gt; **O5-1:** You can wait outside if you wish, Taylor.
&gt; 
&gt; **Taylor:** I&#39;m afraid not, sir.  Protocol for interaction with test subjects.
&gt; 
&gt; **O5-1:** Even him?  Okay.  Scotch, Ray?
&gt; 
&gt; **Lewis:** I don&#39;t think they&#39;ll allow it, unfortunately.
&gt; 
&gt; **O5-1:** They don&#39;t have to know.  No?  All right then.  So how are you feeling?  The team tell me that the latest course is going well.
&gt; 
&gt; **Lewis:** Sure is.  Since your last visit, they&#39;ve changed the formula slightly, and I swear I can feel it.  No side effects, other than a bit of an ache in my jaw.
&gt; 
&gt; **O5-1:** I can see the bruising.  Do they know what that is?
&gt; 
&gt; **Lewis:** Something about bone density or cartilage elasticity - they don&#39;t tell me much.  Surprised you can&#39;t enlighten me.
&gt; 
&gt; **O5-1:** Sometimes I think they don&#39;t want to disappoint me with any bad news.  It&#39;s why I keep coming to talk to you, to see for myself.  That, and the pleasure of your company, of course.
&gt; 
&gt; **Lewis:** Ha.  Charming as always.  Well my company should be pleasant - I&#39;m feeling pretty great.
&gt; 
&gt; **O5-1:** Really?  You&#39;re sure?
&gt; 
&gt; **Lewis:** Absolutely.  I&#39;m sleeping soundly, the scores on my physicals are up, and I haven&#39;t run five miles this quick since I was thirty-five.  They&#39;ve let me train with some of the Alpha-1 boys, and I&#39;m not far off the pace - at my age!  
&gt; 
&gt; **O5-1:** You&#39;ll show those kids who&#39;s boss yet.
&gt; 
&gt; **Lewis:** Well, whatever they&#39;ve got me on, it&#39;s working.
&gt; 
&gt; **O5-1:** You might have a couple less grey hairs, too.
&gt; 
&gt; **Lewis:** Might be.  So, what&#39;s keeping you busy?
&gt; 
&gt; **O5-1:** Oh, you know, the usual worries.  All memetics at the moment.  Nothing on the K-scale, but we just lost two good researchers to mercury poisoning.
&gt; 
&gt; **Lewis:** Sorry to hear that.
&gt; 
&gt; **O5-1:** What?  Oh, that&#39;s okay.  It&#39;s just the work seems to get more and more dangerous.
&gt; 
&gt; **Lewis:** You&#39;re doing the right thing though.  The people here believe in it.  I believe in it.
&gt; 
&gt; **O5-1:** I know, but - I shouldn&#39;t have asked you to do this.  It&#39;s too risky.
&gt; 
&gt; **Lewis:** We knew that when we started.  It will be worth it.
&gt; 
&gt; **O5-1:** I&#39;m not sure.  Look, I shouldn&#39;t really tell you this, but - there&#39;s been an issue with one of the other Amrita subjects.  He - 
&gt; 
&gt; **Lewis:** His name was Thomson, right?  Yes, I&#39;ve heard about it.  
&gt; 
&gt; **O5-1:** &lt;//exhales//&gt; Then you&#39;ll ask to drop out of the project?
&gt; 
&gt; **Lewis:** No! Sorry sir, but I signed up for this, and I want to see it through.
&gt; 
&gt; **O5-1:** But you&#39;ve seen him - what it did.
&gt; 
&gt; **Lewis:** That&#39;s a different batch, though.
&gt; 
&gt; **O5-1:** On the same project, the same theories.
&gt; 
&gt; **Lewis:** You&#39;ll figure it out.  That&#39;s what you do.  That&#39;s why we&#39;re here.  Sir, you know - &lt;//silence, 3 seconds//&gt; - you know they would want you to keep going.
&gt; 
&gt; **O5-1:** I hope so.  Yes.  You&#39;re right, of course.  Thanks for reminding me.  I just worry - I guess I&#39;m getting old.
&gt; 
&gt; **Lewis:** Well, someone has to.
&gt; 
&gt; **O5-1:** Ha.  Thanks, Ray.  See you next time?
&gt; 
&gt; **Lewis:** I&#39;ll be here.
&gt; 
@@@@
[[/tab]]
[[/tabview]]
@@@@
[[tabview]]
[[tab Incomplete medical records - 1947 (continued)]]

**Medical Records - Site 19 - Project Amrita**

[[=image scan4.PDF width=650px]]
@@@@
[[=image scan12.PDF width=650px]]
@@@@
[[=image scan3.PDF width=650px]]
@@@@
[[=image scan8.PDF width=650px]]
@@@@
[[/tab]]
[[/tabview]]
@@@@
[[&gt;]]
[[[https://scp-wiki.wikidot.com/psul-001/offset/7 |Open next file ...]]]
[[/&gt;]]
@@@@
@@@@
[[module css]]
.computed {
border: 1px black solid;
width: 50%;
display: inline-block;
text-align: left;
padding: 3px;
}
.computed:before {
content:&#34;Computed Code&#34;;
font-weight: bold;
border-bottom: solid 1px black;
width: 100%;
}
.rawcode {
border: black solid 1px;
width: 50%;
display: inline-block;
text-align: left;
padding: 3px;
}
.rawcode:before{
content:&#34;Raw Code&#34;;
text-align: center;
font-weight: bold;
border-bottom: solid 1px black;
width: 100%;
}
.codebox {
display: inline-block;
width: 100%;
text-align: center;
}
.yui-navset .yui-nav .selected a em,  .yui-navset .yui-nav a em{
padding: 0.25em .75em; 
top: 0px;
margin-bottom: 0px;
}
.yui-navset .yui-nav .selected a {
background: gray;
}
.yui-navset .yui-nav .selected {
margin: 0px;
}
.yui-navset .yui-nav .selected a, .yui-navset .yui-nav .selected a:focus, .yui-navset .yui-nav .selected a:hover, .yui-navset .yui-nav .selected a {
background: gray;
}
.yui-navset .yui-nav a, .yui-navset .yui-navset-top .yui-nav a {
background-color: none;
background-image: none;
}
.yui-navset .yui-nav a {
background: none;
}
.yui-navset .yui-nav li{
margin: 0px;
}
.yui-navset .yui-content {
background-color: #FDFCF9; 
}
[[/module]]</textarea></pre>
  </div>

</div>

<div id="footer">
  
    <em>Last updated 2023-07-15 21:44:37.341364.</em>
  
</div>
</body>